AAAAAA
Results: 1-25/40
Authors:
Cheung, KL
Robertson, JFR
Citation: Kl. Cheung et Jfr. Robertson, Preoperative hormone therapy trials for breast cancer, BREAST, 10(1), 2001, pp. 1-5
Authors:
Tan, SM
Cheung, KL
Willsher, PC
Blamey, RW
Chan, SY
Robertson, JFR
Citation: Sm. Tan et al., Locally advanced primary breast cancer: medium-term results of a randomised trial of multimodal therapy versus initial hormone therapy, EUR J CANC, 37(18), 2001, pp. 2331-2338
Authors:
Whitlock, JPL
Evans, AJ
Jackson, L
Chan, SY
Robertson, JFR
Citation: Jpl. Whitlock et al., Imaging of metastatic breast cancer: Distribution and radiological assessment at presentation, CL ONCOL-UK, 13(3), 2001, pp. 181-186
Authors:
Nabholtz, JM
Bonneterre, J
Buzdar, A
Robertson, JFR
Thurlimann, B
Steinberg, M
Webster, A
von Euler, M
Citation: Jm. Nabholtz et al., Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer? Reply, J CL ONCOL, 19(9), 2001, pp. 2580-2582
Authors:
Cheung, KL
Evans, AJ
Robertson, JFR
Citation: Kl. Cheung et al., The use of blood tumour markers in the monitoring of metastatic breast cancer unassessable for response to systemic therapy, BREAST CANC, 67(3), 2001, pp. 273-278
Authors:
Kenny, FS
Willsher, PC
Gee, JMW
Nicholson, RI
Pinder, SE
Ellis, IO
Robertson, JFR
Citation: Fs. Kenny et al., Change in expression of ER, bcl-2 and MIB1 on primary tamoxifen and relation to response in ER positive breast cancer, BREAST CANC, 65(2), 2001, pp. 135-144
Authors:
Cheung, KL
Nicholson, RI
Blamey, RW
Robertson, JFR
Citation: Kl. Cheung et al., Selection of primary breast cancer patients for adjuvant endocrine therapy- is oestrogen receptor alone adequate?, BREAST CANC, 65(2), 2001, pp. 155-162
Authors:
Gee, JMW
Robertson, JFR
Ellis, IO
Nicholson, RI
Citation: Jmw. Gee et al., Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer, INT J CANC, 95(4), 2001, pp. 247-254
Authors:
Kenny, FS
Gee, JMW
Nicholson, RI
Ellis, IO
Morris, TM
Watson, SA
Bryce, RP
Robertson, JFR
Citation: Fs. Kenny et al., Effect of dietary GLA plus /-tamoxifen on the growth, ER expression and fatty acid profile of ER positive human breast cancer xenografts, INT J CANC, 92(3), 2001, pp. 342-347
Authors:
Bonneterre, J
Buzdar, A
Nabholtz, JMA
Robertson, JFR
Thurlimann, B
von Euler, M
Sahmoud, T
Webster, A
Steinberg, M
Citation: J. Bonneterre et al., Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma - Results of two randomized trials designed for combined analysis, CANCER, 92(9), 2001, pp. 2247-2258
Authors:
Crombie, N
Rampaul, RS
Pinder, SE
Elston, CW
Robertson, JFR
Ellis, IO
Citation: N. Crombie et al., Extent of ductal carcinoma in situ within and surrounding invasive primarybreast carcinoma, BR J SURG, 88(10), 2001, pp. 1324-1329
Authors:
Cheung, KL
Howell, A
Robertson, JFR
Citation: Kl. Cheung et al., Preoperative endocrine therapy for breast cancer, ENDOCR-R CA, 7(3), 2000, pp. 131-141
Authors:
Hui, R
Macmillan, RD
Kenny, FS
Musgrove, EA
Blamey, RW
Nicholson, RI
Robertson, JFR
Sutherland, RL
Citation: R. Hui et al., INK4a gene expression and methylation in primary breast cancer: Overexpression of p16(INK4a) messenger RNA is a marker of poor prognosis, CLIN CANC R, 6(7), 2000, pp. 2777-2787
Authors:
Kollias, J
Macmillan, RD
Sibbering, DM
Burrell, H
Robertson, JFR
Citation: J. Kollias et al., Effect of evening primrose oil on clinically diagnosed fibroadenomas, BREAST, 9(1), 2000, pp. 35-36
Authors:
Jacobs, E
Bulpitt, PCA
Coutts, IGC
Robertson, JFR
Citation: E. Jacobs et al., New calmodulin antagonists inhibit in vitro growth of human breast cancer cell lines independent of their estrogen receptor status, ANTI-CANC D, 11(2), 2000, pp. 63-68
Authors:
Bonneterre, J
Thurlimann, B
Robertson, JFR
Krzakowski, M
Mauriac, L
Koralewski, P
Vergote, I
Webster, A
Steinberg, M
von Euler, M
Citation: J. Bonneterre et al., Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: Results of the tamoxifen or arimidex randomized group efficacy and tolerability study, J CL ONCOL, 18(22), 2000, pp. 3748-3757
Authors:
Cheung, KL
Pinder, SE
Paish, C
Sadozye, AH
Chan, SY
Evans, AJ
Blamey, RW
Robertson, JFR
Citation: Kl. Cheung et al., The role of blood tumor marker measurement (using a biochemical index score and c-erbB2) in directing chemotherapy in metastatic breast cancer, INT J B MAR, 15(3), 2000, pp. 203-209
Authors:
Cheung, KL
Graves, CRL
Robertson, JFR
Citation: Kl. Cheung et al., Tumour marker measurements in the diagnosis and monitoring of breast cancer, CANC TR REV, 26(2), 2000, pp. 91-102
Authors:
Gee, JMW
Barroso, AF
Ellis, IO
Robertson, JFR
Nicholson, RI
Citation: Jmw. Gee et al., Biological and clinical associations of c-jun activation in human breast cancer, INT J CANC, 89(2), 2000, pp. 177-186
Authors:
Knowlden, JM
Gee, JMW
Robertson, JFR
Ellis, IO
Nicholson, RI
Citation: Jm. Knowlden et al., A possible divergent role for the oestrogen receptor alpha and beta subtypes in clinical breast cancer, INT J CANC, 89(2), 2000, pp. 209-212
Authors:
Yip, SS
Crew, AJ
Gee, JMW
Hui, R
Blamey, RW
Robertson, JFR
Nicholson, RI
Sutherland, RL
Daly, RJ
Citation: Ss. Yip et al., Up-regulation of the protein tyrosine phosphatase SHP-1 in human breast cancer and correlation with GRB2 expression, INT J CANC, 88(3), 2000, pp. 363-368
Authors:
Kenny, FS
Pinder, SE
Ellis, IO
Gee, JMW
Nicholson, RI
Bryce, RP
Robertson, JFR
Citation: Fs. Kenny et al., Gamma linolenic acid with tamoxifen as primary therapy tn breast cancer, INT J CANC, 85(5), 2000, pp. 643-648
Authors:
Evans, AJ
Robertson, JFR
Citation: Aj. Evans et Jfr. Robertson, Magnetic resonance imaging versus radionuclide scintigraphy for screening in bone metastases, CLIN RADIOL, 55(8), 2000, pp. 653-653
Authors:
Wilson, ARM
Evans, AJ
Robertson, JFR
Citation: Arm. Wilson et al., The missing mammographic abnormality, BR J SURG, 87(3), 2000, pp. 374-374
Authors:
Nicholson, RI
McClelland, RA
Robertson, JFR
Gee, JMW
Citation: Ri. Nicholson et al., Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer, ENDOCR-R CA, 6(3), 1999, pp. 373-387